We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+16%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$324M
AUM Growth
+$28.5M
Cap. Flow
-$2.62M
Cap. Flow %
-0.81%
Top 10 Hldgs %
32.96%
Holding
465
New
18
Increased
159
Reduced
243
Closed
13

Top Buys

Rank Stock Value
1
EDV icon
Vanguard World Funds Extended Duration ETF
EDV
+$3.29M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.96M
3
AAPL icon
Apple
AAPL
+$1.92M
4
PCVX icon
Vaxcyte
PCVX
+$1.9M
5
META icon
Meta Platforms (Facebook)
META
+$1.81M

Top Sells

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$5.11M
2
AMZN icon
Amazon
AMZN
+$4.12M
3
ABNB icon
Airbnb
ABNB
+$2.92M
4
ADI icon
Analog Devices
ADI
+$2.79M
5
BEKE icon
KE Holdings
BEKE
+$2.12M

Sector Composition

Rank Sector Weight
1 Technology 41.8%
2 Consumer Discretionary 21.38%
3 Healthcare 19.26%
4 Communication Services 6.74%
5 Financials 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRBU icon
401
Caribou Biosciences
CRBU
$169M
$3.42K ﹤0.01%
805
-22
-3% -$99
EXAI
402
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$3.41K ﹤0.01%
576
-11
-2% -$67
GRCL
403
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$3.4K ﹤0.01%
893
-10
-1% -$28
EGRX
404
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.34K ﹤0.01%
172
-5
-3% -$119
URGN icon
405
UroGen Pharma
URGN
$2.39B
$3.18K ﹤0.01%
307
-6
-2% -$66
PRLD icon
406
Prelude Therapeutics
PRLD
$456M
$3.09K ﹤0.01%
687
+38
+6% +$227
SGMO
407
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.93K ﹤0.01%
2,252
-31
-1% -$42
QSI icon
408
Quantum-Si Incorporated
QSI
$182M
$2.85K ﹤0.01%
1,593
-31
-2% -$49
NGM
409
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$2.8K ﹤0.01%
1,080
-32
-3% -$114
PEPG icon
410
PepGen
PEPG
$201M
$2.78K ﹤0.01%
311
-9
-3% -$118
NBP
411
NovaBridge Biosciences American Depositary Shares
NBP
$216M
$2.7K ﹤0.01%
903
-22
-2% -$71
KPTI icon
412
Karyopharm Therapeutics
KPTI
$46M
$2.67K ﹤0.01%
100
-2
-2% -$86
FULC icon
413
Fulcrum Therapeutics
FULC
$284M
$2.67K ﹤0.01%
810
-26
-3% -$76
CMPS
414
Compass Pathways
CMPS
$1.97B
$2.59K ﹤0.01%
313
-8
-2% -$68
ABOS icon
415
Acumen Pharmaceuticals
ABOS
$181M
$2.59K ﹤0.01%
538
-17
-3% -$81
NSTG
416
DELISTED
NanoString Technologies, Inc.
NSTG
$2.52K ﹤0.01%
621
-13
-2% -$96
IPSC icon
417
Century Therapeutics
IPSC
$353M
$2.47K ﹤0.01%
781
-18
-2% -$58
CDXS icon
418
Codexis
CDXS
$172M
$2.45K ﹤0.01%
875
-18
-2% -$58
ANNX icon
419
Annexon
ANNX
$873M
$2.45K ﹤0.01%
695
+49
+8% +$214
KZR
420
DELISTED
Kezar Life Sciences
KZR
$2.33K ﹤0.01%
95
+2
+2% +$52
ALT icon
421
Altimmune
ALT
$570M
$2.28K ﹤0.01%
646
-22
-3% -$99
GRTS
422
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$2.27K ﹤0.01%
1,166
+36
+3% +$84
RNAC icon
423
Cartesian Therapeutics
RNAC
$263M
$2.25K ﹤0.01%
67
-2
-3% -$72
ATRA icon
424
Atara Biotherapeutics
ATRA
$83.1M
$2.07K ﹤0.01%
51
-1
-2% -$57
TVRD
425
Tvardi Therapeutics
TVRD
$22.1M
$2K ﹤0.01%
20
– –
15 16
17
18 19

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q2 2023 Portfolio in Review

As of Q2 2023, China Universal Asset Management Company held 465 positions worth $324M, up 9.6% from $295M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

China Universal Asset Management Company's Q2 2023 filing shows 18 new, 159 increased, 243 reduced and 13 closed positions. Its largest new stake was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M. The largest sale was iQIYI, an estimated $5.11M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • China Universal Asset Management Company's largest Q2 2023 buy was Vanguard World Funds Extended Duration ETF: 37,709 shares worth $3.28M.
  • China Universal Asset Management Company added most to Alnylam Pharmaceuticals in Q2 2023, an estimated $1.96M increase.
  • China Universal Asset Management Company's biggest Q2 2023 reduction was iQIYI, cutting an estimated $5.11M.
  • China Universal Asset Management Company fully exited Block Inc in Q2 2023, selling an estimated $1.35M.
  • China Universal Asset Management Company's ten largest holdings make up 33% of its $324M portfolio in Q2 2023.
  • China Universal Asset Management Company opened 18 new positions and closed 13 in Q2 2023.
  • China Universal Asset Management Company's portfolio value rose 9.6% quarter-over-quarter to $324M.

Based on China Universal Asset Management Company's 13F filing for Q2 2023, filed 28 Jul 2023.